Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Casgevy gains UK label expansion for younger patient population

Oct 30, 2026, 12:34 PM

Read Full Article → Casgevy gains UK label expansion for younger patient population

Casgevy gains UK label expansion for younger patient population

Translate article text

Choose a language and wait for the translated text.

Following this MHRA label expansion, UK patients with β-thalassemia and sickle cell disease aged five and up can now receive Casgevy.

Casgevy gains UK label expansion for younger patient population | PharmaVoice